Slate Medicines | $130,000,000 | (Feb 25, 2026)
Letter AI | $40,000,000 | (Feb 25, 2026)
Subject | $28,000,000 | (Feb 25, 2026)
Baird Capital
United States
- Chicago, IL
- 05/12/2022
- Series C
- $31,500,000
Baird Capital makes venture capital, growth equity and private equity investments in strategically targeted sectors around the world. We are value creators who identify exceptional opportunities and partner with senior industry executives to build world-class companies. Our in-depth sector knowledge, deep relationships with entrepreneurial management teams and global network of 60 investment and operating professionals in the United States, U.K. and Asia help ensure that we consistently drive value in our portfolio companies.
For disclosures please visit: http://www.rwbaird.com/about-baird/important-disclosures.aspx
- Industry Venture Capital and Private Equity Principals
- Website https://www.bairdcapital.com/
- LinkedIn https://www.linkedin.com/company/baird-capital-partners-europe-limited/
Related People
Joanna ArrasCo Founder
United States -
Greater Chicago Area
Venture capital investor focused on early- and expansion- stage companies that leverage technology to solve business problems or just make life easier. Business models of choice include SaaS, marketplaces, and high value services. Prior experience in investment banking and corporate development.
KrisAtWork | $3,000,000 | (Feb 25, 2026)
Centauri Therapeutics Limited | $8,107,170 | (Feb 25, 2026)
Slang AI | $36,000,000 | (Feb 25, 2026)
Brilliant Harvest Inc. | $4,000,000 | (Feb 25, 2026)
Koah | $20,500,000 | (Feb 25, 2026)
Nimble | $47,000,000 | (Feb 25, 2026)
General Magic | $7,200,000 | (Feb 25, 2026)
Circadian Risk Inc. | $6,000,000 | (Feb 25, 2026)
Neural Earth | $9,300,000 | (Feb 25, 2026)
Jampack AI | $3,200,000 | (Feb 25, 2026)